Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis

International Journal of Clinical Rheumatology

Volumn 8, Issue 1, 2013, Pages 109-121

  Angeles Han, Sheila T ^a,b   Yeh, Steven ^a   Vogler, Larry B ^a,b  

^a EMORY UNIVERSITY   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

Juvenile arthritis; Juvenile idiopathic arthritis associated uveitis; Ocular disease; Pediatric rheumatology; Risk; Uveitis

Indexed keywords

ANTINUCLEAR ANTIBODY; HLA B27 ANTIGEN; HLA DR1 ANTIGEN; HLA DR11 ANTIGEN;

AGE DISTRIBUTION; ANTIBODY TITER; CATARACT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE EXAMINATION; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; IMMUNOPATHOGENESIS; JUVENILE RHEUMATOID ARTHRITIS; JUVENILE RHEUMATOID ARTHRITIS ASSOCIATED UVEITIS; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REMISSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; UVEITIS; VISUAL ACUITY;

EID: 84873296458     PISSN: 17584272     EISSN: 17584280     Source Type: Journal    
DOI: 10.2217/ijr.12.83     Document Type: Review

References (107)

1. Ravelli A, Martini A.Juvenile idiopathic arthritis. Lancet 369(9563), 767-778 (2007).
2. Sury B, Vesterdal E. Extra-articular lesions in juvenile rheumatoid arthritis. A survey based upon a study of 151 cases. Acta Rheumatologica Scandinavica 14(4), 309-316 (1968).
3. Vesterdal E, Sury B. Iridocyclitis and bandshaped corneal opacity in juvenile rheumatoid arthritis. Acta Ophthalmologica 28(3), 321-335 (1950).
4. Smiley WK. Iridocyclitis in Still's disease. Prognosis and steroid treatment. Trans. Ophthalmol. Soc. UK 85, 351-356 (1965).
5. Stewart AJ, Hill RH. Ocular manifestations in juvenile rheumatoid arthritis. Can. J. Ophthalmol. 2(1), 58-62 (1967).
6. Schaller J, Kupfer C, Wedgwood RJ. Iridocyclitis in juvenile rheumatoid arthritis. Pediatrics 44(1), 92-100 (1969).
7. Calabro JJ, Parrino GR, Atchoo PD, Marchesano JM, Goldberg LS. Chronic iridocyclitis in juvenile rheumatoid arthritis. Arthritis Rheum. 13(4), 406-413 (1970).
8. Kanski JJ. Juvenile arthritis and uveitis. Surv. Ophthalmol. 34(4), 253-267 (1990). (Pubitemid 20098164)
9. Kesen MR, Setlur V, Goldstein DA. Juvenile idiopathic arthritis-related uveitis. Int. Ophthalmol. Clin. 48(3), 21-38 (2008).
10. Kotaniemi K, Savolainen A, Karma A, Aho K. Recent advances in uveitis of juvenile idiopathic arthritis. Surv. Ophthalmol. 48(5), 489-502 (2003). (Pubitemid 38366017)
11. Zierhut M, Michels H, Stubiger N, Besch D, Deuter C, Heiligenhaus A. Uveitis in children. Int. Ophthalmol. Clin. 45(2), 135-156 (2005). (Pubitemid 40570758)
12. Kanski JJ. Uveitis in juvenile chronic arthritis. Clin. Exp. Rheumatol. 8(5), 499-503 (1990). (Pubitemid 20362256)
13. BenEzra D, Cohen E, Behar-Cohen F. Uveitis and juvenile idiopathic arthritis: a cohort study. Clin. Ophthalmol. 1(4), 513-518 (2007).
14. Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology 108(11), 2071-2075 (2001). (Pubitemid 33032781)
15. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology 104(2), 236-244 (1997). (Pubitemid 27088098)
16. Paroli MP, Speranza S, Marino M, Pirraglia MP, Pivetti-Pezzi P. Prognosis of juvenile rheumatoid arthritis-associated uveitis. Eur. J. Ophthalmol. 13(7), 616-621 (2003). (Pubitemid 37229161)
17. Sabri K, Saurenmann RK, Silverman ED, Levin AV. Course, complications and outcome of juvenile arthritis-related uveitis. J. AAPOS 12(6), 539-545 (2008).
18. Chen CS, Roberton D, Hammerton ME. Juvenile arthritis-associated uveitis: visual outcomes and prognosis. Can. J. Ophthalmol. 39(6), 614-620 (2004). (Pubitemid 39472081)
19. Rosenberg AM, Oen KG. The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis. Arthritis Rheum. 29(6), 797-800 (1986). (Pubitemid 16094159)
20. Petty RE, Southwood TR, Manners P et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J. Rheumatol. 31(2), 390-392 (2004). (Pubitemid 38160763)
21. Caspi RR. Understanding autoimmune uveitis through animal models. The Friedenwald Lecture. Invest. Ophthalmol. Vis. Sci. 52(3), 1872-1879 (2011).
22. Nussenblatt RB, Rodrigues MM, Wacker WB, Cevario SJ, Salinas-Carmona MC, Gery I. Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats. J. Clin. Invest. 67(4), 1228-1231 (1981). (Pubitemid 11090565)
23. Hamada M, Ogura Y, Miyamoto K, Nishiwaki H, Hiroshiba N, Honda Y. Retinal leukocyte behavior in experimental autoimmune uveoretinitis of rats. Exp. Eye Res. 65(3), 445-450 (1997). (Pubitemid 27400532)
24. Adamus G, Schmied JL, Hargrave PA, Arendt A, Moticka EJ. Induction of experimental autoimmune uveitis with rhodopsin synthetic peptides in Lewis rats. Curr. Eye Res. 11(7), 657-667 (1992).
25. Caspi RR, Roberge FG, Chan CC et al. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 140(5), 1490-1495 (1988).
26. Xu H, Rizzo LV, Silver PB, Caspi RR. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell. Immunol. 178(1), 69-78 (1997). (Pubitemid 27250281)
27. Caspi RR, Chan CC, Grubbs BG et al. Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. J. Immunol. 152(2), 890-899 (1994).
28. Jones LS, Rizzo LV, Agarwal RK et al. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol. 158(12), 5997-6005 (1997). (Pubitemid 127484009)
29. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090), 235-238 (2006).
30. Luger D, Silver PB, Tang J et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 205(4), 799-810 (2008). (Pubitemid 351549879)
31. Chi W, Yang P, Li B et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt- Koyanagi-Harada disease. J. Allergy Clin. Immunol. 119(5), 1218-1224 (2007). (Pubitemid 46667160)
32. Chi W, Zhu X, Yang P et al. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest. Ophthalmol. Vis. Sci. 49(7), 3058-3064 (2008).
33. Su SB, Silver PB, Grajewski RS et al. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J. Immunol. 175(10), 6303-6310 (2005). (Pubitemid 41598869)
34. Hohki S, Ohguro N, Haruta H et al. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Exp. Eye Res. 91(2), 162-170 (2010).
35. Raveney BJ, Copland DA, Dick AD, Nicholson LB. TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis. J. Immunol. 183(4), 2321-2329 (2009).
36. Grajewski RS, Silver PB, Agarwal RK et al. Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity. J. Exp. Med. 203(4), 851-856 (2006).
37. Keino H, Takeuchi M, Usui Y et al. Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis. Br. J. Ophthalmol. 91(1), 105-110 (2007). (Pubitemid 46094020)
38. Copland DA, Calder CJ, Raveney BJ et al. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am. J. Pathol. 171(2), 580-588 (2007). (Pubitemid 47344690)
39. Mattapallil MJ, Silver PB, Mattapallil JJ et al. Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells. J. Immunol. 187(4), 1977-1985 (2011).
40. Lee RW, Dick AD. Current concepts and future directions in the pathogenesis and treatment of noninfectious intraocular inflammation. Eye (Lond.) 26(1), 17-28 (2012).
41. Horai R, Caspi RR. Cytokines in autoimmune uveitis. J. Interferon Cytokine Res. 31(10), 733-744 (2011)
42. Commodaro AG, Bueno V, Belfort R Jr, Rizzo LV.Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation. Autoimmun. Rev. 10(4), 205-209 (2011).
43. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J. Exp. Med. 201(9), 1479-1486 (2005). (Pubitemid 40664091)
44. Cassidy J, Kivlin J, Lindsley C, Nocton J. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 117(5), 1843-1845 (2006). (Pubitemid 46071421)
45. American Academy of Pediatrics section on rheumatology and section on ophthalmology: guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 92(2), 295-296 (1993).
46. Sim KT, Venning HE, Barrett S, Gregson RM, Amoaku WM. Extended oligoarthritis and other risk factors for developing JIA-associated uveitis under ILAR classification and its implication for current screening guideline. Ocul. Immunol. Inflamm. 14(6), 353-357 (2006). (Pubitemid 44949894)
47. Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 46(6), 1015-1019 (2007). (Pubitemid 47062514)
48. Ozdal PC, Vianna RN, Deschenes J. Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults. Ocul. Immunol. Inflamm. 13(1), 33-38 (2005). (Pubitemid 41702782)
49. Saurenmann RK, Levin AV, Feldman BM et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term follow-up study. Arthritis Rheum. 56(2), 647-657 (2007).
50. Cabral DA, Petty RE, Malleson PN, Ensworth S, Mccormick AQ, Shroeder ML. Visual prognosis in children with chronic anterior uveitis and arthritis. J. Rheumatol. 21(12), 2370-2375 (1994).
51. Woreta F, Thorne JE, Jabs DA, Kedhar SR, Dunn JP. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am. J. Ophthalmol. 143(4), 647-655 (2007).
52. Saurenmann RK, Levin AV, Feldman BM, Laxer RM, Schneider R, Silverman ED. Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Arthritis Rheum. 62(6), 1824-1828 (2010).
53. Bolt IB, Cannizzaro E, Seger R, Saurenmann RK. Risk factors and long-term outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. J. Rheumatol. 35(4), 703-706 (2008). (Pubitemid 351500070)
54. Cassidy JT, Sullivan DB, Petty RE. Clinical patterns of chronic iridocyclitis in children with juvenile rheumatoid arthritis. Arthritis Rheum. 20(Suppl. 2), 224-227 (1977).
55. Ravelli A, Felici E, Magni-Manzoni S et al. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum. 52(3), 826-832 (2005). (Pubitemid 40365105)
56. Nordal EB, Songstad NT, Berntson L, Moen T, Straume B, Rygg M. Biomarkers of chronic uveitis in juvenile idiopathic arthritis: predictive value of antihistone antibodies and antinuclear antibodies. J. Rheumatol. 36(8), 1737-1743 (2009).
57. Manzotti F, Orsoni JG, Zavota L, Cimino L, Zola E, Bonaguri C. Autoimmune uveitis in children: clinical correlation between antinuclear antibody positivity and ocular recurrences. Rheumatol. Int. 21(4), 127-132 (2002). (Pubitemid 34045282)
58. Grassi A, Corona F, Casellato A, Carnelli V, Bardare M. Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease. J. Rheumatol. 34(5), 1139-1145 (2007). (Pubitemid 46774862)
59. Skarin A, Elborgh R, Edlund E, Bengtsson- Stigmar E. Long-term follow-up of patients with uveitis associated with juvenile idiopathic arthritis: a cohort study. Ocul. Immunol. Inflamm. 17(2), 104-108 (2009).
60. Zak M, Fledelius H, Pedersen FK. Ocular complications and visual outcome in juvenile chronic arthritis: a 25-year follow-up study. Acta Ophthalmol. Scand. 81(3), 211-215 (2003). (Pubitemid 36806254)
61. Zulian F, Martini G, Falcini F et al. Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis. J. Rheumatol. 29(11), 2446-2453 (2002). (Pubitemid 35266041)
62. Giannini EH, Malagon CN, Van Kerckhove C et al. Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis. J. Rheumatol. 18(9), 1394-1397 (1991).
63. Glass D, Litvin D, Wallace K et al. Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen- DRw5, iritis, and antinuclear antibody. J. Clin. Invest. 66(3), 426-429 (1980). (Pubitemid 10053905)
64. Melin-Aldana H, Giannini EH, Taylor J et al. Human leukocyte antigen-DRB11104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis. J. Pediatr. 121(1), 56-60 (1992).
65. Miller ML, Fraser PA, Jackson JM et al. Inherited predisposition to iridocyclitis with juvenile rheumatoid arthritis: selectivity among HLA-DR5 haplotypes. Proc. Natl Acad. Sci. USA 81(11), 3539-3542 (1984). (Pubitemid 14122709)
66. Malagon C, Van Kerckhove C, Giannini EH et al. The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: outcome in immunogenetically characterized patients. J. Rheumatol. 19(1), 160-163 (1992).
67. Zeggini E, Packham J, Donn R, Wordsworth P, Hall A, Thomson W. Association of HLA-DRB113 with susceptibility to uveitis in juvenile idiopathic arthritis in two independent data sets. Rheumatology (Oxford) 45(8), 972-974 (2006). (Pubitemid 44283051)
68. Haas JP, Truckenbrodt H, Paul C, Hoza J, Scholz S, Albert ED. Subtypes of HLA-DRB1, 03, 08, 11, 12, 13 and 14 in early onset pauciarticular juvenile chronic arthritis (EOPA) with and without iridocyclitis. Clin. Exp. Rheumatol. 12(Suppl. 10), S7-S14 (1994). (Pubitemid 24254527)
69. Ohno S, Kimura SJ, O'Connor GR, Char DH. HLA antigens and uveitis. Br. J. Ophthalmol. 61(1), 62-64 (1977). (Pubitemid 8031417)
70. Raymaekers A, Foets B, Wouters C, Casteels I. Visual outcome in children with juvenile idiopathic arthritis related uveitis. Bull. Soc. Belge Ophtalmol. (300), 67-72 (2006).
71. Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am. J. Ophthalmol. 143(5), 840-846 (2007).
72. Holland GN, Denove CS, Yu F. Chronic anterior uveitis in children: clinical characteristics and complications. Am. J. Ophthalmol. 147(4), 667-678 e665 (2009).
73. Chia A, Lee V, Graham EM, Edelsten C. Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am. J. Ophthalmol. 135(6), 757-762 (2003). (Pubitemid 36677391)
74. Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology 94(10), 1242-1248 (1987). (Pubitemid 17149332)
75. Tugal-Tutkun I, Havrlikova K, Power WJ, Foster CS. Changing patterns in uveitis of childhood. Ophthalmology 103(3), 375-383 (1996). (Pubitemid 26085891)
76. Edelsten C, Lee V, Bentley CR, Kanski JJ, Graham EM. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br. J. Ophthalmol. 86(1), 51-56 (2002). (Pubitemid 34074885)
77. Chalom EC, Goldsmith DP, Koehler MA et al.Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J. Rheumatol. 24(10), 2031-2034 (1997). (Pubitemid 27431939)
78. Sherry DD, Mellins ED, Wedgwood RJ. Decreasing severity of chronic uveitis in children with pauciarticular arthritis. Am. J. Dis. Child. 145(9), 1026-1028 (1991).
79. Ayuso VK, Ten Cate HA, van der Does P, Rothova A, de Boer JH. Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis. Am. J. Ophthalmol. 149(6), 987-993 (2010).
80. Ayuso VK, Ten Cate HA, Van Der Does P, Rothova A, De Boer JH. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Am. J. Ophthalmol. 149, 994-999 (2010).
81. Kump LI, Castaneda RA, Androudi SN, Reed GF, Foster CS. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology 113(10), 1874-1877 (2006). (Pubitemid 44442436)
82. Kotaniemi K, Kaipiainen-Seppanen O, Savolainen A, Karma A. A population-based study on uveitis in juvenile rheumatoid arthritis. Clin. Exp. Rheumatol. 17(1), 119-122 (1999). (Pubitemid 29099901)
83. Greenwood BM. Polyarthritis in Western Nigeria. II. Still's disease. Ann. Rheum. Dis. 28(6), 617-623 (1969).
84. Schwartz MM, Simpson P, Kerr KL, Jarvis JN. Juvenile rheumatoid arthritis in African Americans. J. Rheumatol. 24(9), 1826-1829 (1997). (Pubitemid 27394525)
85. Saurenmann RK, Rose JB, Tyrrell P et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum. 56(6), 1974-1984 (2007). (Pubitemid 47110396)
86. Haffejee IE, Raga J, Coovadia HM. Juvenile chronic arthritis in black and Indian South African children. S. Afr. Med. J. 65(13), 510-514 (1984). (Pubitemid 14134589)
87. Aggarwal A, Misra RN. Juvenile rheumatoid arthritis in India - rarity of antinuclear antibody and uveitis. Indian J. Pediatr. 63(3), 301-304 (1996). (Pubitemid 126552052)
88. Heinz C, Mingels A, Goebel C, Fuchsluger T, Heiligenhaus A. Chronic uveitis in children with and without juvenile idiopathic arthritis: differences in patient characteristics and clinical course. J. Rheumatol. 35(7), 1403-1407 (2008). (Pubitemid 352000792)
89. Angeles-Han S, Yeh S. Prevention and management of cataracts in children with juvenile idiopathic arthritis-associated uveitis. Curr. Rheumatol. Rep. 14(2), 142-149 (2012).
90. Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology 117(7), 1436-1441 (2010).
91. Sijssens KM, Rothova A, Van De Vijver DA, Stilma JS, De Boer JH. Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis. Am. J. Ophthalmol. 144(4), 574-579 (2007).
92. Martin CM, Lacomba MS, Molina CI, Chamond RR, Galera JM, Estevez EC. Levels of soluble ICAM-1 and soluble IL-2R in the serum and aqueous humor of uveitis patients. Curr. Eye Res. 20(4), 287-292 (2000). (Pubitemid 30428159)
93. Arocker-Mettinger E, Asenbauer T, Ulbrich S, Grabner G. Serum interleukin 2-receptor levels in uveitis. Curr. Eye Res. 9(Suppl.), 25-29 (1990). (Pubitemid 20295596)
94. Plskova J, Greiner K, Muckersie E, Duncan L, Forrester JV. Interferon-alpha: a key factor in autoimmune disease? Invest. Ophthalmol. Vis. Sci. 47(9), 3946-3950 (2006). (Pubitemid 46044311)
95. Kilmartin DJ, Fletcher ZJ, Almeida JA, Liversidge J, Forrester JV, Dick AD. CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis. Invest. Ophthalmol. Vis. Sci. 42(6), 1285-1292 (2001). (Pubitemid 32381971)
96. Dick AD. Serological tests for monitoring and predicting disease severity, course, and outcome of autoimmune intraocular inflammation. Br. J. Ophthalmol. 82(8), 856-857 (1998). (Pubitemid 28408139)
97. Mizuki N, Meguro A, Ota M et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat. Genet. 42(8), 703-706 (2010).
98. Remmers EF, Cosan F, Kirino Y et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat. Genet. 42(8), 698-702 (2010).
99. Thompson SD, Sudman M, Ramos PS et al. The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1. Arthritis Rheum. 62(11), 3265-3276 (2010).
100. Heiligenhaus A, Foeldvari I, Edelsten C et al. Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res. (Hoboken) 64(9), 1365-1372 (2012).
101. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first International Workshop. Am. J. Ophthalmol. 140(3), 509-516 (2005). (Pubitemid 41224845)
102. Felius J, Stager DR Sr, Berry PM et al. Development of an instrument to assess vision-related quality of life in young children. Am. J. Ophthalmol. 138(3), 362-372 (2004). (Pubitemid 39208562)
103. Gothwal VK, Lovie-Kitchin JE, Nutheti R. The development of the LV Prasad-Functional Vision Questionnaire: a measure of functional vision performance of visually impaired children. Invest. Ophthalmol. Vis. Sci. 44(9), 4131-4139 (2003). (Pubitemid 37051538)
104. Birch EE, Cheng CS, Felius J. Validity and reliability of the Children's Visual Function Questionnaire (CVFQ). J. AAPOS 11(5), 473-479 (2007). (Pubitemid 47539938)
105. Khadka J, Ryan B, Margrain TH, Court H, Woodhouse JM: Development of the 25-item Cardiff Visual Ability Questionnaire for Children (CVAQC). Br. J. Ophthalmol. 94(6), 730-735 (2010).
106. Angeles-Han ST, Griffin KW, Lehman TJ et al. The importance of visual function in the quality of life of children with uveitis. J. AAPOS 14(2), 163-168 (2010).
107. Angeles-Han ST, Griffin KW, Harrison MJ et al. Development of a vision-related quality of life instrument for children ages 8-18 years for use in juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res. (Hoboken) 63(9), 1254-1261 (2011).